Interleukin-6 as unfavorable prognostic factor in patients affected by Covid-19 and hip fracture.

Pantalone, A; Bruni, D; Pantalone, P; Buda, R

Pantalone, A; Bruni, D; Pantalone, P; Buda, R.

Pantalone A; Orthopaedic and Traumatology Unit, Department of Medicine and Science of Aging, University G. "d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Bruni D; Orthopaedic and Traumatology Unit, Department of Medicine and Science of Aging, University G. "d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Pantalone P; Biodiscovery Institute and School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Buda R; Orthopaedic and Traumatology Unit, Department of Medicine and Science of Aging, University G. "d'Annunzio" of Chieti-Pescara, Chieti, Italy.

J Biol Regul Homeost Agents ; 35(1): 353-354, 2021.

Article in English | MEDLINE | ID: covidwho-1055399

Subject(s)

COVID-19/complications; Hip Fractures/complications; Interleukin-6/blood; COVID-19/blood; Hip Fractures/blood; Humans; Prognosis

Keywords

COVID-19; Interleukin-6; SARS-CoV-2; hip fracture

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / COVID-19 / Hip Fractures Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Biol Regul Homeost Agents Journal subject: Biology / Biochemistry Year: 2021 Document Type: Article Affiliation country: 20-410-L

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google